Trademark: 86803969
Word
CLINICAL CHEMISTRY . . . IT'S WHAT WE DO!
Status Date
Monday, January 8, 2018
Filing Date
Thursday, October 29, 2015
Published for Opposition
Tuesday, April 11, 2017
Abandoned Date
Monday, January 8, 2018
5 diagnostic substances, preparations, and materials, namely, chemical, biological and diagnostic reagents and prepared laboratory media for medical purposes; assay kits and reagents for chemical or immunochemical analysis of body fluids or cell-culture supernatants for medical purposes; diagnostic reagents for medical use, diagnostic calibrators for medical use that are used to calibrate the performance of a medical diagnostic reagent, and diagnostic controls for monitoring the performance of diagnostic reagents and calibrators on an assay device for medical use; kits comprised of diagnostic reagents for medical use; kits comprised of diagnostic calibrators for medical use that are used to calibrate the performance of a medical diagnostic reagent; kits comprised of diagnostic controls diagnostic controls for monitoring the performance of diagnostic reagents and calibrators on an assay device for medical use; and kits comprised of assay kits and reagents for chemical or immunochemical analysis of body fluids or cell-culture supernatants for medical purposes; blood plasmas in the nature of control plasmas; fibrinolytic system reagents for medical purposes; antibodies to fibrinolytic proteins for medical purposes; antibodies to coagulation proteins for medical purposes; chromogenic substrates for medical purposes; biochemical reagents for medical purposes; coagulation inhibitors for use in medical diagnostic testing
10 diagnostic testing apparatus and instruments, namely, clinical chemistry analyzers, molecular analyzers, hematological analyzers, and immunoassay analyzers for the analysis of biological samples for clinical medical screening, monitoring and diagnostic purposes; kits comprised of clinical chemistry analyzers for medical purposes; kits comprised of molecular analyzers for medical purposes; kits comprised of hematological analyzers for medical purposes; kits comprised of immunoassay analyzers for medical purposes; cuvettes for containing test sample, reagent and calibrator materials all of the aforesaid for the analysis of biological samples for clinical medical screening, monitoring and diagnostic purposes; clinical chemistry analyzers for medical purposes; urine analyzing apparatus for medical use; automatic urine analyzing apparatus and instruments for medical use; bilirubin tester for diagnosis for medical purposes; immunoassay apparatus for diagnosis, namely, turbidimetric agglutination analyzers, radioimmunoassay analyzers, enzyme immunoassay analyzers, fluorescence immunoassay analyzers, and chemiluminescent and bioluminescent immunoassay analyzers for medical purposes; testing and diagnostic apparatus and instruments, namely, urine analyzers, endotoxin analyzers, all for in vitro use for medical purposes; apparatus for measuring the concentration of constituents of the blood, namely, blood analyzers for medical purposes, and parts and fittings for all the aforesaid goods
"CLINICAL CHEMISTRY"
CLINICAL CHEMISTRY . . . IT IS WHAT WE DO
Jan 8, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jan 8, 2018
Abandonment - No Use Statement Filed
Jun 6, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 11, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2017
Published For Opposition
Mar 22, 2017
Notification Of Notice Of Publication E-Mailed
Mar 6, 2017
Law Office Publication Review Completed
Mar 3, 2017
Exparte Appeal Terminated
Mar 1, 2017
Approved For Pub - Principal Register
Feb 16, 2017
Teas/Email Correspondence Entered
Feb 16, 2017
Correspondence Received In Law Office
Feb 15, 2017
Teas Request For Reconsideration Received
Feb 15, 2017
Ex Parte Appeal-Instituted
Feb 15, 2017
Jurisdiction Restored To Examining Attorney
Feb 15, 2017
Exparte Appeal Received At Ttab
Aug 16, 2016
Notification Of Final Refusal Emailed
Aug 16, 2016
Final Refusal E-Mailed
Aug 16, 2016
Final Refusal Written
Jul 26, 2016
Teas/Email Correspondence Entered
Jul 25, 2016
Correspondence Received In Law Office
Jul 25, 2016
Teas Response To Office Action Received
Jan 26, 2016
Notification Of Non-Final Action E-Mailed
Jan 26, 2016
Non-Final Action E-Mailed
Jan 26, 2016
Non-Final Action Written
Jan 20, 2016
Assigned To Examiner
Nov 24, 2015
Applicant Amendment Prior To Examination - Entered
Nov 23, 2015
Assigned To Lie
Nov 4, 2015
Notice Of Pseudo Mark E-Mailed
Nov 3, 2015
Teas Voluntary Amendment Received
Nov 3, 2015
New Application Office Supplied Data Entered In Tram
Nov 2, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
